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ABSTRACT
MeCP2 is a highly abundant chromatin architectural
protein with key roles in post-natal brain devel-
opment in humans. Mutations in MeCP2 are
associated with Rett syndrome, the main cause of
mental retardation in girls. Structural information
on the intrinsically disordered MeCP2 protein is
restricted to the methyl-CpG binding domain;
however, at least four regions capable of DNA and
chromatin binding are distributed over its entire
length. Here we use small angle X-ray scattering
(SAXS) and other solution-state approaches to in-
vestigate the interaction of MeCP2 and a truncated,
disease-causing version of MeCP2 with nucleo-
somes. We demonstrate that MeCP2 forms defined
complexes with nucleosomes, in which all four
histones are present. MeCP2 retains an extended
conformation when binding nucleosomes without
extra-nucleosomal DNA. In contrast, nucleosomes
with extra-nucleosomal DNA engage additional
DNA binding sites in MeCP2, resulting in a rather
compact higher-order complex. We present ab
initio envelope reconstructions of nucleosomes
and their complexes with MeCP2 from SAXS data.
SAXS studies also revealed unexpected sequence-
dependent conformational variability in the nucleo-
somes themselves.
INTRODUCTION
Methyl-CpG binding protein 2 (MeCP2) is a chromatin-
associated protein that is highly abundant in neuronal
cells, amounting to about one MeCP2 molecule for
every two nucleosomes (1). Mutations in the coding
region of MeCP2 lead to Rett syndrome (RTT), a
neuro-developmental disease which is the main cause
of mental retardation and autistic behaviour in girls
[reviewed in ref. (2)]. The incidence of RTT is about 1 in
every 10000–15000 female births (3). MeCP2 is also
implicated in multiple other developmental disorders, sug-
gesting that it occupies a central role in the post-natal
development of the human brain (4). There are currently
over 200 mutations found in the MeCP2 gene that cause
RTT, most of which cluster around eight ‘hot spots’
distributed throughout the protein sequence (Figure 1).
Four of the ﬁve most frequent RTT-causing mutations
introduce stop codons into the transcription repression
domain (TRD); the ﬁfth most frequent mutation termin-
ates at the end of the TRD (R294X; http://mecp2.chw
.edu.au/mecp2/). A recent view suggests that MeCP2 dys-
function induces changes in the expression levels of thou-
sands of genes, with a majority of genes being activated by
MeCP2 (5). This suggests that MeCP2 under normal
cellular conditions might not act as a gene speciﬁc tran-
scriptional regulator as previously assumed (6,7), but
instead might dampen transcriptional noise genome-wide
in a DNA methylation-dependent manner (1).
Human MeCP2 isoform e2 is composed of 486 amino
acids and is a monomer in solution (8). Circular dichroism
(CD) data of full length MeCP2 indicate that it is 60%
unstructured (9), consistent with theoretical predictions
[FoldIndex (http://bip.weizmann.ac.il/ﬂdbin/ﬁndex)] (10).
Limited protease digestion of full length MeCP2 has
identiﬁed six ‘domains’ (9) (Figure 1). Two of these have
been particularly well characterized functionally: the
methyl-CpG binding domain (MBD) that binds both
unmethylated and methylated DNA, spanning amino
acids 76–163 (11) and the TRD (amino acids 203–310)
(12). Stop codons between amino acids 168 and 294 are
among the most frequently found mutations in RTT
patients (http://mecp2.chw.edu.au/mecp2/). No mis-sense
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1–78). To date, structural information is only available for
the MBD (amino acids 77–163) alone and in complex with
a short fragment of methylated DNA (13,14). The other
ﬁve MeCP2 domains are mostly unstructured as judged by
both CD and theoretical predictions. Thus, MeCP2 falls
into the category of proteins known as ‘intrinsically dis-
ordered’. Traditional structural techniques such as X-ray
crystallography and NMR cannot provide useful struc-
tural information for the full length protein.
The MBD of MeCP2 not only recognizes methylated
DNA (15) but also binds unmethylated DNA (16,17).
Additional unmethylated DNA binding sites (DBDs)
have been mapped to the intervening domain (ID)
between the MBD and TRD (17,18), the TRD (9,17)
and the CTDa (Figure 1) (17). Thus, there are at least
four regions spanning residues 77–354 that contribute to
unmethylated DNA binding in vitro. MeCP2 also binds to
nucleosomes and nucleosomal arrays in vitro (17,19) and
to chromatin in vivo (18). Early in vitro studies claimed
that MeCP2 forms discrete complexes with nucleosomes
via the MBD in a methyl-CpG dependent manner. The
carboxyl-terminal segment of MeCP2 contributes to
binding both to free DNA and to the nucleosome and to
MeCP2-dependent chromatin compaction (11,17). More
recently it was demonstrated that MeCP2 interacts with
higher afﬁnity with nucleosomes with methylated DNA
(17) and that the presence of the extra-nucleosomal
‘linker’ DNA in the nucleosome is essential for this inter-
action (20). MeCP2 protects an additional 11bp from
digestion with micrococcal nuclease, indicating that the
MeCP2 binding site on nucleosomes is close to the
linker DNA entry–exit region. Electron microscopy of
the MeCP2-nucleosome complexes may be interpreted as
a nucleosome-MeCP2-nucleosome ‘sandwich’ structure in
40% of the cases examined (20), consistent with multiple
DNA binding sites on each MeCP2 monomer.
Binding of recombinant human MeCP2 to positioned
nucleosomal arrays in the absence of DNA methylation
promotes their compaction into highly condensed struc-
tures (16). However, how MeCP2-mediated chromatin
compaction occurs is completely unknown. One recent
view (supported by the high abundance of MeCP2 espe-
cially in neuronal cells) is that MeCP2 may function
similar to linker histones (21) by serving as a key regulator
of chromatin structure in neurons, thereby globally
contributing to gene regulation. Thus, understanding
how MeCP2 interacts with the nucleosome, the fundamen-
tal building block of eukaryotic chromatin, is essential to
understand the function of this enigmatic protein in health
and disease.
Here, we present a rigorous biophysical and biochem-
ical analysis of the complexes formed between MeCP2 and
nucleosomes without and with extra-nucleosomal linker
DNA. We also analyse truncated versions of MeCP2
(encompassing amino acids 1–305 and 74–305, respec-
tively) both of which serve as models for the ﬁfth most
frequent RTT mutant R294X. Our studies show that
MeCP2 forms deﬁned complexes with nucleosomes irre-
spective of the presence of extra-nucleosomal linker DNA.
MeCP2 binds preferentially to nucleosomes with linker
DNA by engaging additional DNA binding domains.
We have obtained structural data of nucleosomes and
MeCP2-nucleosome complexes from small-angle X-ray
scattering (SAXS) experiments. From the SAXS experi-
ments we identiﬁed different conformational states of nu-
cleosomal DNA dependent on the DNA sequence used to
form nucleosomes. Our SAXS data further allow us to
hypothesize how MeCP2 might interact with nucleosomes
and nucleosomal arrays to cause chromatin compaction.
Experimental procedures
Expression and puriﬁcation of MeCP2. Recombinant full
length human MeCP2 (isoform e2) was expressed in the
IMPACT system (New England Biolabs) and puriﬁed as
described (9). Puriﬁed full length MeCP2 and fragments
1–305 and 78–305 (Figure 1) were dialysed into storage
buffer (10mM Tris, pH 7.5, 10% glycerol, 10mM NaCl,
0.25mM EDTA, 1mM b-mercaptoethanol) and stored
at 4C.
Nucleosomal DNA and nucleosome reconstitution. Either
147-bp palindromic DNA fragments derived from
human a-satellite DNA (22) or 146- and 165-bp DNA
fragments derived from the strong positioning ‘601’
DNA sequence (23) were used (Supplementary
Figure S1). Nucleosome reconstitution with recombinant
histones was done as previously described (24), resulting
in three types of nucleosomes referred to as A-Nuc147
(a-sat sequence); W-Nuc146 and W-Nuc165 (both ‘601’
sequence), respectively.
Electrophoretic mobility shift assays. A-Nuc147 or
W-Nuc165 (15mM) were incubated with increasing
Figure 1. Domain structure of MeCP2. Dashed lines indicate the constructs used here, in addition to full length protein. NTD: N-terminal domain;
MBD: methyl-CpG DNA binding domain, TRD: transcription repression domain, CTD: C-terminal domain. Red bars above indicate mapped DNA
binding regions. The ﬁve most frequent mutations are indicated (percent occurrence given in brackets; nonsense mutations are indicated by asterisks).
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1mM DTT and 0, 100 or 300mM NaCl in 10ml reaction
volumes at room temperature for 30min. The products
were electrophoresed on pre-run 5% polyacrylamide gels
(mono/bis ratio of 35:1) in 0.2X TB (45mM Tris, 45mM
borate pH 8.3) at 150V for 75min at 4C.
Nucleosome competition assay. W-Nuc146 was pre-
incubated with MeCP2 at a 1–1.5 molar ratio in 10mM
Tris pH 7.5, 100mM NaCl, 2% glycerol, 0.2mM TCEP
at room temperature for 30min. Increasing amounts
(0.25–1 molar ratio to W-Nuc146) of Alexa Fluor-488
labeled W-Nuc165 was added to the pre-incubated
W-146Nuc-MeCP2 complex and incubated at room tem-
perature for another 30min before resolving on a 5%
native PAGE gel. The reverse competition assay was
done under identical conditions. The products were
electrophoresed on pre-run 5% polyacrylamide gel as
described above. The gel was visualized both by ﬂuores-
cence and ethidium bromide staining. Competition assays
with 53bp DNA were performed under the same
conditions.
Analytical ultracentrifugation. For sedimentation velocity
experiments in the analytical ultracentrifuge, A-Nuc147 or
W-Nuc165 alone or in complex with MeCP2 at the
indicated molar ratios was prepared at 600nM.
Sedimentation velocity experiments were performed at
low salt concentration (10mM Tris, pH 7.5, 1mM
EDTA, 1mM DTT). Sedimentation velocity experiments
were done in a Beckman XL-I or XL-A analytical ultra-
centrifuge with absorbance detection at 260nm. Scans
were collected at a radial step resolution of 0.003cm at
25000rpm for 5h. Boundaries were analysed using the
Ultrascan software (version 7.3). This analysis gives a
diffusion-corrected integral distribution of sedimentation
coefﬁcients, G(s). Sedimentation coefﬁcients were cor-
rected to that in water at 20C. The solvent densities
were calculated in Ultrascan (25). The partial speciﬁc
volumes of the samples were calculated from the
primary DNA and amino acid sequence within Ultrascan.
Size-exclusion chromatography/multi-angle light
scattering. Size-exclusion chromatography combined
with multi-angle light scattering (SEC-MALS) (Wyatt
technologies) was performed at the Advanced Light
Source (ALS) in Berkeley, California. A Superose-6 PC
3.2/30 column (2.4ml total volume, GE Healthcare) with
a ﬂow rate of 40ml/min was used to separate the sample
before performing the MALS measurement. Experiments
were done with 25ml 11.5mM of A-Nuc147 or W-Nuc165
alone or each of these in a 1:1 complex with MeCP2-WT
in the same buffer as above (10mM Tris, pH 7.5, 1mM
EDTA, 1mM DTT). The same samples were used
for SAXS (see below). They were at least 90% homoge-
neous as determined by electrophoretic mobility shift
assays (EMSA). The molar mass for each molecule was
determined with the ASTRA software (Wyatt
Technologies). SEC-MALS is an accurate tool for
determining the molar mass of proteins in solution. It is
also an extremely sensitive method for detecting
whether—and how much of—any aggregates have
formed, because the light scattering response is directly
proportional to the weight-averaged molar mass (MW)
of the sample being measured, multiplied by the concen-
tration (see application notes under http://www.wyatt
.eu/index.php?id=proteins&L=0%27).
SAXS data collection and analysis. SAXS data for all
samples were collected at the SIBYLS beam line (12.3.1)
at the ALS (Berkeley) with an X-ray energy of 10keV
( =1.2398A ˚ ). A Mar CCD detector was used to record
the scattering data. A 15ml sample was placed in a 1mm
thick chamber with two windows of 25mm mica. The
distance between the sample and the detector was 1.5m.
Stock solutions of MeCP2, A-Nuc147, W-Nuc146 and
W-Nuc165 each at 7.5mg/ml, and MeCP2 in complex
with W-Nuc146 or W-Nuc165 at 9.4mg/ml (the concen-
tration of nucleosome remains the same in the complex
when compared with the control nucleosome sample) were
prepared. Additional samples were prepared by diluting
the stock solutions to two-third and one-third concentra-
tion with reference buffer (10mM Tris, pH 7.5, 1mM
EDTA, 1mM DTT). Additional experiments were per-
formed on A-Nuc147 at higher dilution (ﬁnal concentra-
tion 0.8mg/ml).
The intensity curves (intensity as a function of
momentum of transfer s=4p sin(y)/  with 2y the total
scattering angle) were measured at all concentrations,
and corrected for buffer scattering. Repeat exposures
were taken to check for radiation damage, while two dif-
ferent exposures, typically of 6 and 60s in duration, were
taken to optimize the signal-to-noise ratio and avoid
detector saturation. Initial data processing was performed
with the program PRIMUS (26). The radius of gyration,
Rg, was estimated by Guinier analysis (27) in PRIMUS
using low-angle data (Rg<1.3); the maximum particle di-
mension was estimated by regularized indirect Fourier
transform with the program AUTOGNOM, an auto-
mated version of GNOM (28), which provides the P(r)
function. The P(r) function is a histogram of inter-atomic
distances and goes to zero at the maximum intra-
molecular distance dmax. The P(r) functions were
normalized by scaling the function to I0 for each sample.
At least 10 low-resolution molecular envelopes were
calculated from the scattering data for each model, using
the program DAMMIN (29) in slow mode and
superimposed using SUPCOMB, providing a normalized
spatial discrepancy (NSD) value which is zero for identical
objects and larger than one for objects that systematically
differ from one another (30). Finally, the pre-aligned
models were averaged with DAMAVER (31), giving an
effective occupancy of each voxel. A convex shell of all
models can be generated by keeping all occupied voxels,
while ﬁltering at half-maximal occupancy provides
‘ﬁltered’ models. These models were used for all subse-
quent analyses. To visualize the results, the reconstructed
models were converted to volumetric maps using real
space convolution with a Gaussian kernel with the
program Situs (32,33). A kernel width of 6A ˚ and voxel
spacing of 1A ˚ were used. Molecular representations were
made with VMD (34). An appropriate scale bar was added
4124 Nucleic Acids Research, 2011,Vol.39, No. 10to the ﬁnal envelopes by displaying a ribbon scale in VMD
and using this scale to generate the scale bars in ﬁnal
editing, so all images are shown on the same scale.
RESULTS
MeCP2 forms deﬁned complexes with nucleosomes
Nucleosomes reconstituted with a 147bp DNA fragment
derived from a-sat DNA [A-Nuc-147; (22)] were incubated
with increasing amounts of full length human
recombinant MeCP2 and the complexes were resolved
on a 5% native polyacrylamide gel (Figure 2A). The
addition of increasing amounts of MeCP2 resulted in a
progressive reduction of free A-Nuc147 and the appear-
ance of discretely shifted and super-shifted bands.
Nucleosomes in the off-centered position (Figure 2A,
lane 2, upper band) shifted preferentially. The same
behavior was observed with RTT MeCP2 fragments
1–305 or 78–305 (which encompasses the MBD, ID and
TRD; Figure 2B), as well as with the individual
MBD or TRD fragments (data not shown). Two bands
A
C
E
D
B
Figure 2. MeCP2 forms deﬁned complexes with nucleosomes in vitro. Gels in (A, B, C and E) were stained in ethidium bromide, the gel in D was
stained with Coomassie blue. (A) Increasing amounts of MeCP2 were added to A-Nuc147 resulting in retarded mobility of A-Nuc147. In this
preparation, nucleosomes (in absence of MeCP2) migrate as two bands on the gel, representative of two different positions of the histone octamer
with respect to the DNA (24). (B) Mobility shifts were also observed with MeCP2 N-terminal fragments (amino acids 1–305 or 78–305), indicating
that the N-terminal portion of MeCP2 is sufﬁcient for this interaction. (C and D) Upper and lower bands (C) were excised and eluted from the gel
before loading onto an 18% SDS gel (D). (E) Electrophoretic mobility shifts were also observed with W-Nuc165, with both full length and the
N-terminal MeCP2 (78–305) fragment.
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were excised from the native gel (Figure 2C) and loaded
onto an 18% SDS gel (Figure 2D). All four histones as
well as MeCP2(1–305) were present in both bands. The
relative intensities of the four core histones and MeCP2
bands are very similar in the two shifted complexes
(Figure 2D, lanes 4 and 5). Because the upper shifted
band reverts to the lower shifted band upon addition of
more nucleosomes (data not shown), we interpret the
upper super-shifted complex as having multiple MeCP2
molecules bound to one nucleosome. Similar
MeCP2-nucleosome complexes were obtained after incu-
bation in the presence of 150 and 300mM NaCl (data not
shown). Nucleosomes reconstituted with a 165bp DNA
fragment centered on a strong nucleosome positioning
sequence [‘601’; (23); W-Nuc165] exhibited the same be-
haviour in EMSAs as the linker-less A-Nuc147 nucleo-
somes in the presence of full length and truncated
MeCP2 (Figure 2E).
The stoichiometry and histone composition of the
nucleosome-MeCP2 complexes was further investigated
using SEC-MALS. This method provides information
about sample purity and monodispersity (SEC) and a
direct measure of the particle molecular weight (MALS).
The particle molecular weight is the basis for stoichiom-
etry determination of complexes in solution. MeCP2-WT
was added to A-Nuc147 or W-Nuc165 to a point at which
over 90% of MeCP2-nucleosome complexes migrating in
the ﬁrst shifted band were obtained at an approximate
molar ratio of 1.5 MeCP2 to 1 nucleosome. These
samples were injected individually onto a Superose-6 size
exclusion column connected to a light scattering detector.
Samples containing either full length MeCP2, and
A-Nuc147 or W-Nuc165 in the absence of full length
MeCP2 were used as controls. Each chromatogram
displays a single symmetric peak, indicating the homogen-
eity of the preparations (Supplementary Figure S2). The
analysis of the molar mass at the center part of the peak
reveals mono-dispersity for all samples, as evident by
the mass distribution line in Supplementary Figure S2
(Table 1). For full length MeCP2, A-Nuc147 and
W-Nuc165, the molar mass derived from the center part
of the peak measured by light scattering is in close agree-
ment with the respective calculated molecular weight
(Table 1). For both nucleosome–MeCP2 complexes, the
measured molar mass agreed very well with the calculated
molecular weight for a 1:1 molar ratio of nucleosome to
MeCP2 (Table 1). These data also show that no histones
are released upon interaction with MeCP2.
To better understand the structures of the MeCP2-
nucleosome complexes identiﬁed by EMSA experiments,
we employed sedimentation velocity in the analytical
ultracentrifuge (SV-AUC). Full length MeCP2 is a
monomer in solution with a sedimentation coefﬁcient
of 2.3 S and an anomalously high frictional coefﬁcient
due to its intrinsically disordered nature (9). The
diffusion-corrected sedimentation coefﬁcient distributions
of A-Nuc147 alone and in complex with MeCP2 at two
different ratios are shown in Figure 3A. Under our experi-
mental conditions, A-Nuc147 sediments as a homoge-
neous 11 S species, consistent with earlier studies of
isolated nucleosome core particles (35). Quite surprisingly,
the 1:1.5 and 1:3.0 MeCP2–A-Nuc147 complexes
sedimented more slowly than the nucleosome itself
(10.4 S and 10.7 S, respectively). Given that a ratio
of 1:1.5 produced a 1:1 MeCP2–A-Nuc147 complex
(Supplementary Figure S2; see above) and that the sedi-
mentation coefﬁcient of a di-nucleosome is 15 S (36), the
SV-AUC data indicate that the 20% increase in molecular
weight due to one MeCP2 binding to a single A-Nuc147 is
offset by the increase in frictional coefﬁcient of the result-
ing MeCP2–A-Nuc147 complex. Importantly, the gel
shown in Figure 3B was run after the samples had been
subjected to SV-AUC. Thus, we conclude that the increase
in electrophoretic shifts obtained upon increasing the
MeCP2-nucleosome ratio from 1.5 to 3.0 are due to the
interaction of one, then additional MeCP2 molecule(s),
with a single A-Nuc147.
We repeated the SV-AUC studies with the MeCP2–
W-Nuc165 complexes. At a 1:1 molar ratio, the sedimen-
tation coefﬁcient of W-Nuc165 decreased as with
A-Nuc147 (Figure 3C). However, at a 2:1 MeCP2 per nu-
cleosome molar ratio, the sedimentation coefﬁcient distri-
bution was extremely heterogeneous and ranged from
12 to >30 S. The electrophoretic behaviour of the
two samples is shown in Figure 3D. Thus, binding
of MeCP2 to W-Nuc165 leads to both anomalous
changes in frictional properties of the complex and
protein-dependent ‘bridging’ of multiple W-Nuc165 par-
ticles into higher order aggregates (e.g. dimers, trimers).
Taken together, our analyses of the MeCP2–A-Nuc147
and MeCP2–W-Nuc165 complexes indicate that linker
DNA is required for bridging, presumably reﬂecting en-
gagement of multiple MeCP2 DNA binding sites with
available extra-nucleosomal DNA segments.
MeCP2 preferentially interacts with nucleosomes
containing extra-nucleosomal linker DNA
Previous quantitative studies have observed robust inter-
action with nucleosomes assembled on longer DNA
Table 1. SEC-MALS analysis of nucleosomes and nucleosome-
MeCP2 complexes
Molecule or complex SEC-MALS
Molecular weight (kDa)
Observed (%) Calculated
BSA 66.47±2 67.0
MeCP2 full length 56.00±4 52.44
A-Nuc147 198.0±2 205.0
A-Nuc147-MeCP2 full length 251.4±2 257.9 (1:1)
W-Nuc165 202.8±1 208.95
W-Nuc165-MeCP2 full length 253.9±0.6 261.4 (1:1)
Data were obtained from the experiments shown in Supplementary
Figure S2. The observed and calculated values show a good corres-
pondence and demonstrate that the complexes between nucleosomes
and MeCP2 occur at a 1:1 ratio.
4126 Nucleic Acids Research, 2011,Vol.39, No. 10fragments containing linker DNA (11,20). To differentiate
the relative binding afﬁnities of MeCP2 for nucleosomes
with and without linker DNA, we used a competition
assay. To exclude possible sequence-dependent differences
between the two nucleosomes and to directly investigate
the effect of linker DNA on binding afﬁnity, we prepared
nucleosomes with the central 146bp of the 601 sequence
used for W-Nuc165 (W-Nuc146; Supplementary Figure
S1). W-Nuc146 was pre-incubated with full length
MeCP2 at a molar ratio ranging from 1 to 1.5.
Increasing amounts of ﬂuorescently labeled W-Nuc165
was added and incubated at room temperature for
another 30min before resolving the complexes by 5%
native PAGE. Fluorescently labeled W-Nuc165 success-
fully competes with W-Nuc146 for MeCP2, as observed
in an increase in the amount of W-Nuc165–MeCP2
complex, accompanied by an increase of free W-Nuc146
(Figure 4A, lanes 3–6). This is particularly apparent
when only ﬂuorescently labeled W-Nuc165 is visualized
(Figure 4B, lanes 4–6). At lower concentrations, all
of the W-Nuc165 is found in complex with MeCP2.
Conversely, when increasing amounts of W-Nuc146 were
added as a competitor to the pre-formed W-Nuc165-
MeCP2 complex, the amount of 165NCP-MeCP2
complexes remains nearly unchanged (Figure 4A and B,
lanes 8–10).
To investigate whether MeCP2 prefers free DNA over
extra-nucleosomal nucleosomal linker DNA, a similar
competition assay was performed between W-Nuc165
and a non-nucleosomal 53bp DNA fragment. Figure 4C
demonstrates that addition of free 53bp DNA to the
pre-formed W-Nuc165–MeCP2-WT complex results in a
decrease in the amount of W-Nuc165–MeCP2 complex,
with a concomitant increase in the amount of W-Nuc165
and newly formed complexes between 53bp DNA and
MeCP2 (Figure 4C, lanes 8–10). Together, our results
demonstrate that MeCP2 discriminates against
histone-bound nucleosomal DNA and also prefers
binding to longer free DNA fragments over the relatively
short (10bp) linker DNA presented in W-Nuc165.
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Figure 3. Analytical ultracentrifugation of MeCP2-nucleosome complexes. (A) Sedimentation velocity analysis of A-Nuc147 and A-Nuc147-MeCP2
complexes in 20mM Tris–HCl, pH 7.5, 1mM EDTA, 1mM DTT (TCS). Data sets: ﬁlled circles A-147Nuc; squares – A-147Nuc-MeCP2 1:1
complex; triangles—A-147Nuc-MeCP2 1:2 complex (B) A-Nuc147-MeCP2 complexes analysed in (A) were run on a 5% native gel after the sedi-
mentation experiment and stained with ethidium bromide. The complexes were still intact after the sedimentation experiments. (C) Sedimentation
velocity analysis of W-Nuc165 and W-Nuc165-MeCP2 complexes, under conditions as described in (A). Filled circles: W-Nuc165, squares:
W-Nuc165 with an equimolar amount of MeCP2, diamonds: 2-fold molar excess of MeCP2. (D) Ethidium bromide stained 5% native gel of a
constant amount of W-Nuc165 titrated with increasing amounts of MeCP2, numbers on the top indicate molar ratios of MeCP2. Asterisks indicate
the samples that were analysed by AUC.
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conformation in nucleosomes
SAXS provides information on the dimensions and shape
of macromolecules in solution. Additionally, structural in-
formation can be calculated from SAXS data at 10–50A ˚
resolution (37,38). We used SAXS to obtain complemen-
tary information on nucleosome-MeCP2 complexes.
As an important control, we ﬁrst obtained scattering
data from nucleosomes in the absence of MeCP2. While
the crystal structure of A-Nuc147 is known to a very high
resolution (39) and the structures of W-Nuc146 to
medium resolution (40), the structure for W-Nuc165 is
not known. The published structures of A-Nuc147 and
W-Nuc146 are very similar: both structures show approxi-
mately 1.75 turns of double stranded DNA wound around
the histone octamer. Figure 5A (based on the A-Nuc147
structure) is representative for both crystal structures. To
allow for a direct comparison between nucleosomes with
and without linker DNA and to test whether DNA
sequence had an effect on overall nucleosome structure
in solution, we performed SAXS on all three nucleosomes.
The same samples that were used for SAXS were shown to
be highly homogeneous using EMSA and by SEC-MALS
(Supplementary Figure S2).
Guinier analysis (27) is performed at very low scattering
angles and it predicts a linear relationship between ln(I)
and s
2, for ideal solutions. From the slope of the line the
radius of gyration can be determined. Non-ideal solution
behaviour, such as aggregation can be visualized in
non-linear components. This analysis demonstrates that
none of the nucleosome samples exhibit signs of aggrega-
tion; repeat exposure of the same sample shows no sign of
radiation damage (data not shown). Inspection of the P(r)
data (a histogram of intra-particle vectors) reveals the
bell-shaped curves that are characteristic of globular
complexes with well-deﬁned maximum particle sizes for
all three nucleosome preparations (Supplementary
Figure S3). W-Nuc146 (with 601 DNA) displayed a dmax
AB
C
Figure 4. MeCP2 preferentially interacts with nucleosomes with extra-nucleosomal linker DNA. (A) MeCP2 was pre-incubated with W-Nuc146, and
an increasing amount of ﬂuorescently labeled W-Nuc165 (W-Nuc165*) was added as a competitor (lanes 4–6). In lanes 8–10, W-Nuc146 was added
as competitor to pre-incubated W-Nuc165*-MeCP2 complex. (B) Fluorescence view of the gel shown in (A), demonstrating the increase in
ﬂuorescently labeled 165NCP-MeCP2 complex when W-Nuc165* was added as a competitor (lanes 4–6), but no signiﬁcant change was observed
in lanes 9, 10 when W-146Nuc was added as a competitor. (C) Competition assay between 53bp DNA and W-Nuc165. 53mer DNA was added to
pre-incubated W-Nuc165*-MeCP2 complex, resulting in the formation of MeCP2-DNA complexes and free nucleosome (lanes 8–10).
4128 Nucleic Acids Research, 2011,Vol.39, No. 10of 123A ˚ , consistent with that obtained from X-ray crys-
tallography (115A ˚ ; Table 2). The experimental scatter-
ing data and the P(r) functions for this particle
superimpose very well with scattering data simulated
from the nucleosome crystal structure (pdb entry 1AOI,
ﬂexible histone tails removed; Figure 5C) using the
program CRYSOL (41). The molecular envelope was
calculated from the scattering data using the program
DAMMIN. The reconstructed image consists of an
average of at least 10 individual reconstructions; the indi-
vidual models agree well with each other, as judged by the
normalized spatial discrepancy (see Supplementary Table
S1 for statistics associated with averaging). The envelope
for W-Nuc146 corresponds closely to the nucleosome
crystal structure (compare Figure 5A and B). The nucleo-
some dyad-region is clearly identiﬁable in the molecular
100Å
100Å
A 100Å
60Å
100Å
100Å
100Å
60Å
B
0.0 0.1 0.2 0.3 0.4
1
10
100
1000
10000
Crystal Structure (Chi=3.6)
W-Nuc146
s
L
o
g
(
I
)
C
20 40 60 80 100 120
0.0000
0.0005
0.0010
0.0015
W-Nuc146
Crystal Structure
R(Å)
P
(
R
)
/
I
(
0
)
Figure 5. SAXS analysis of W-Nuc146 as a proof of concept. (A) The crystal structure of the nucleosome core particle [PDB entry 1AOI, (22)],
which consists of two copies each of H2A (yellow), H2B (red), H3 (blue), H4 (green) and 147bp of DNA (gray), with the histone tails removed,
serves as a reference. The particle measures approximately 10010060A ˚ in size. To allow comparison of particle sizes, these size indicators are
consistently used in envelope reconstructions in this paper. (B) Molecular envelope derived from SAXS data for W-Nuc146. This envelope is an
average of ten reconstructions, acquired with the program DAMMIN (29) in slow mode. Movies of these envelopes are available in Supplementary
Data, giving a better appreciation of three-dimensional views of these envelopes. (C) (Left panel) Experimental scattering data (red) superimposed
with simulated data from the crystal structure (black), generated with the program CRYSOL (41) with PDB entry 1AOI as input (histone tails
removed from the model). The CRYSOL   value for the match of the crystal structure with the experimental data is shown in the ﬁgure (value in
parentheses). (Right panel) The same data after inversion to P(r) functions by the program AUTOGNOM (28). Both graphs show that the crystal
structure is an excellent model to explain the experimental scattering data.
Nucleic Acids Research, 2011,Vol.39, No. 10 4129envelope, since the envelope is narrower at the location
of the dyad axis, the only region on the nucleosome
where a single layer of DNA double helix is located
(Supplementary movie). At the low ionic strength condi-
tions used here, the ﬂexible histone tails do not extend
away from the surface of the nucleosome but likely are
closely associated with the nucleosomal DNA (42).
A-Nuc147 (with a-sat DNA) is slightly larger (dmax of
145A ˚ ; Table 2), indicating differences compared with the
corresponding crystal structure. This is also obvious from
the comparison of the experimental scattering curve with a
scattering curve calculated from the crystal structure
(Figure 6B.1). Envelopes calculated from the experimental
data show a shape that does not correspond to the crys-
tal structure (compare Figure 6A with Figure 5A).
Preparations were carefully checked with native PAGE
and SEC-MALS to exclude the possibility of contamin-
ants and inhomogeneity, respectively, and similar results
have been obtained from three independent nucleosome
preparations. We interpret this changed shape by partial
unpeeling of nucleosomal DNA from the histone octamer
in at least a signiﬁcant fraction of the nucleosomes
in solution. In forward calculations, a nucleosome with
6–10bp of DNA unpeeled from the body of the histone
octamer gave a much better match to the experimental
intensity curve (Figure 6B.1). Furthermore, this interpret-
ation is supported by increased sensitivity of the DNA
ends towards micrococcal nuclease digestion compared
with W-Nuc146 (Supplementary Figure S4).
The dmax of W-Nuc165 was 148A ˚ , a size that is consist-
ent with expectations from the addition of 7 and 11bp
to the two ends of W-Nuc146 (Table 2). A model in
which 7 and 11bp of DNA were added to either side of
the canonical nucleosome is a better match in forward
calculations than the crystal structure. An average
envelope is shown in Figure 6C.
MeCP2 becomes less extended upon interaction
with W-Nuc165
Analysis of the SAXS data for full length MeCP2 further
documents that MeCP2 is an extended, largely disordered
molecule [Table 2; compare Kratky plots in
Supplementary Figure S6 for A-Nuc147, MeCP2 alone
and in complex with A-Nuc147; (8)]. The extended
nature is also apparent from its P(r) function, which
shows many more long intra-particle distances than a
globular molecule and a large maximum (linear) particle
dimension, dmax (Figure 7A). Both features are indicative
of an extended molecule. Upon complex formation with
A-Nuc147, MeCP2 maintains a rather extended conform-
ation, as seen in the P(r) function of the complex and in a
dmax of the complex that is 50A ˚ larger than that obtained
for nucleosome alone (Table 2). Ab initio calculated enve-
lopes demonstrate that the basic shape of the nucleosome
is maintained and display an asymmetric relatively narrow
extension which we interpret to be MeCP2 (Figure 7C).
Because the structure of full length MeCP2 is unknown
and the protein is known to be mostly disordered (9), rigid
body modeling of the complex is not feasible. A particle of
A-Nuc147 in complex with a fragment of MeCP2 that
only contains the ﬁrst of at least three DNA binding
sites [MeCP2(74–305); Figure 1] exhibits only a slightly
increased dmax compared with the unbound nucleosome
(Table 2). This suggests that the DBDs in this entire
fragment are engaged in interactions, resulting in a
global shape and size for the complex that does not
differ signiﬁcantly from that of the unbound nucleosome.
Both of these particles represent 1:1 stoichiometric
complexes between MeCP2 and the nucleosome, as
veriﬁed by SEC-MALS, and consistent with the Porod
volumes (Supplementary Figure S2, Table 2).
The volumes calculated for a W-Nuc146-MeCP2
particle suggest that this nucleosome interacts with more
than one molecule of full length MeCP2 (its stoichiometry
had not been conﬁrmed by SEC-MALS prior to SAXS
data collection). The obtained complexes are even
more extended than those between full length MeCP2
and A-Nuc147 (Table 2). Finally, the complex between
W-Nuc165 and either full length MeCP2 or
MeCP2(74–305) is only slightly larger than W-Nuc165 in
the absence of MeCP2 (dmax of 151 and 164–A ˚ , respect-
ively; Table 2 and Figure 7B). These data suggest that
MeCP2 interacts differently with nucleosomes without
Table 2. Rg and dmax of MeCP2, nucleosomes and MeCP2-nucleosome complexes, obtained from Small Angle X-ray Scattering
Molecule or complex Rg (A ˚ ) dmax (A ˚ ) Experimental Porod
Vol. (10
5)A ˚ 3
Theoretical Vol for
(NCP)1(MeCP2)1 (10
5)A ˚ 3
W-Nuc146 (‘601’ DNA) [3] 41.6±0.5 123 3.62±0.12
W-Nuc146-MeCP2 full length 64.7±1.3 222 10.11±0.34 5.2
A-Nuc147 (a-sat DNA) [3] 43.9±0.6 145 3.69±0.13
A-Nuc147-MeCP2(78-305) 45.5±0.4 156 3.41±0.12 3.9
A-Nuc147-MeCP2 full length 54.7±0.6 194 5.09±0.06 5.2
W-Nuc165 (‘601’ DNA) [3] 42.1±0.3 148 3.64±0.14
W-Nuc165–MeCP2(78–305) 43.2±0.2 151 3.98±0.15 3.9
W-Nuc165–MeCP2 full length [2] 46.5±0.1 164 4.36±0.12 5.2
MeCP2(78–305) 37.0±0.9 86 0.22±0.00
MeCP2 full length 62.5±4.5 198 1.53±0.06
dmax was determined with AUTOGNOM, an automated version of GNOM (28). The number in square brackets lists the number of individual
nucleosome preparations and data collection iterations for each sample (if done more than once). Porod volumes and their error estimates were
derived from AUTOPOROD (47). The last column in the table lists the expected particle exclusion volumes under the assumption that 1:1 complexes
are formed between the nucleosomes and MeCP2.
4130 Nucleic Acids Research, 2011,Vol.39, No. 10and with linker DNA. Limited proteolysis of
nucleosome-bound MeCP2 indeed revealed subtle differ-
ences in the protection of MeCP2 bound to W-Nuc146
and W-Nuc165 (Supplementary Figure S5B, C, E and
F). MeCP2 bound to W-Nuc146 was degraded more
rapidly and with more intermediate bands than MeCP2
bound to W-Nuc165. Together, these data illustrate the
unique way in which MeCP2 interacts with the nucleo-
some, in particular with its linker DNA, and demonstrates
the plasticity of MeCP2.
DISCUSSION
MeCP2 is an intrinsically disordered protein for which
only limited structural information exists. Here, we
present the biophysical and structural characterization of
several MeCP2-nucleosome complexes. We demonstrate
that one molecule of MeCP2 forms a well-deﬁned
complex with nucleosomes with and without extra-
nucleosomal linker DNA, without displacing any of the
core histones. The molecular dimensions obtained from
SAXS experiments demonstrate that MeCP2, which is
extended and disordered in its free state, assumes a less
extended conformation upon interacting with nucleo-
somes containing linker DNA, but remains extended
when interacting with nucleosomes without DNA
linkers. This suggests that additional DNA binding
domains in MeCP2 become engaged upon the interaction
with linker DNA and nucleosomes. Together, our data
allow us to build a working model for MeCP2-nucleosome
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Figure 6. SAXS reveals sequence-dependent conformational heterogeneity in nucleosomes. (A) The average molecular envelope reconstructed from
SAXS data for A-Nuc147. It is distinctly different from the envelope shown in Figure 5B and has a less round character. (B.1) The experimental
scattering data for A-Nuc147 (red), simulated data from the crystal structure 1AOI (histone tails removed, black) and simulated data from a model
for A-Nuc147 (blue) are superimposed. The CRYSOL   values for the match of the respective models with the experimental data are shown in
parentheses in the ﬁgure. A cartoon of a new model for A-Nuc147 is shown in the inset. The model was made by rearranging the terminal six DNA
base pairs on each end. (B.2) Experimental scattering data for W-Nuc165 (red), simulated data from the crystal structure 1AOI (histone tails
removed, black) and simulated data from a model for W-Nuc165 (blue) are superimposed. CRYSOL   values are shown for each model. A cartoon
of the model is shown in the inset. The model was made by extending the DNA by 7 and 11bp, respectively. (C) Average molecular envelope
reconstructed for W-165Nuc.
Nucleic Acids Research, 2011,Vol.39, No. 10 4131interactions (Figure 8). Finally, SAXS experiments reveal
unexpected differences in DNA end conformations
between nucleosomes reconstituted with two different
DNA sequences.
Ab initio envelope calculations without prior knowledge
of the structures can reveal valuable information on the
shape of macromolecules at 10–50A ˚ resolution. It must be
pointed out however that protein and DNA have different
X-ray scattering properties and as such the approximation
of a molecular envelope with uniform density deduced
from SAXS of a complex containing both DNA and
protein does not strictly hold true. However, our proof
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Figure 7. SAXS data show that MeCP2 interacts differently with A-147Nuc compared with W-165Nuc. (A) Normalized P(r) functions for A-Nuc147
and complexes with full length and truncated MeCP2 (78–305) show that the complex of the nucleosome and MeCP2 has approximately the same
dimension as the sum of its parts. (B) Normalized P(r) functions for W-Nuc165 and complexes with full length and truncated MeCP2 show that the
complex is similar in size and character to the nucleosome by itself. (C) Superposition of average envelopes reconstructed from SAXS data, with the
A-Nuc147—MeCP2 complex in transparent gray and the corresponding nucleosome in blue. (D) Same as (C) for the W-Nuc165 – MeCP2 complex
and W-Nuc165, respectively.
4132 Nucleic Acids Research, 2011,Vol.39, No. 10of concept SAXS experiment with W-Nuc146 shows a re-
markable agreement between the reconstructed envelope
and the canonical crystal structure, perhaps with an
‘emphasized’ density for DNA. The fact that the crystal
structure is a good model to predict and explain the scat-
tering data, and that the 3D crystal structure ﬁts the re-
constructed envelope well, veriﬁes the reconstruction as a
reliable representation of the molecules in solution.
Unexpectedly, the A-Nuc147 nucleosome that has been
used for crystal structure determination (A-Nuc147) (43)
appears to exist in a state in which both terminal 6–10bp
of DNA are dissociated from the histone octamer in
solution. This interpretation is supported by increased sus-
ceptibility of these nucleosomes to micrococcal nuclease
digestion. Our results are consistent with weakened
histone–DNA interactions for the terminal base pairs, as
predicted from the crystal structure (22) and determined
by single molecule experiments (44). The apparent dis-
agreement between the solution state observed for
A-Nuc147 and the crystal structure can be explained by
the fact that the ends of the DNA are engaged in essential
crystal contacts in the crystal lattice (22) and thus the
‘closed conformation’ is selected during the crystallization
process. The observed differences between nucleosomes
reconstituted with DNAs with similar lengths, but differ-
ent sequence suggests a contribution of DNA sequence
to nucleosome conformation. It should be pointed out
that SAXS data were obtained at very low salt conditions;
furthermore, additional DNA sequences must be tested to
validate this concept.
Previously SAXS was used to analyse nucleosomes
prepared from native tissues, resulting in nucleosomes
with a range of DNA sequence and lengths and histone
post-translational modiﬁcations (42). Nucleosomes with
an average DNA length of 146 and 165bp were shown
to have a dmax of 137A ˚ at low ionic strength, in agree-
ment with the values for A-Nuc147 and W-Nuc165 listed
in Table 1. With increasing ionic strength, Mangenot et al.
(42) found an increase in dmax, presumably due to the
dissociation of the histone tails from the DNA. The di-
mensions for the nucleosomes reported here for low-salt
conditions are slightly smaller (and in case of W-Nuc146 a
better match to the crystal structure) than those published
earlier. Later SAXS experiments with recombinant
nucleosomes reconstituted with tail-deleted versions of
H2A and H2B and full length H3 and H4 on a 146bp
fragment derived from the 5S rRNA gene, resulted in
subtly altered scattering curves which were interpreted as
a possible partial dissociation of DNA ends (45). These
differences occur in the same region of the intensity plot as
observed when comparing A-Nuc147 and W-Nuc146
(0.13s0.16).
It has been reported previously that extra-nucleosomal
linker DNA is essential for MeCP2 interactions with
Figure 8. Models for MeCP2–nucleosome interactions: nucleosomes and MeCP2 are shown to scale, according to the dmax values determined by
SAXS (Table 2). Note that dmax for highly extended proteins such as MeCP2 is notoriously difﬁcult to determine. The model takes into account
that MeCP2 binds near the nucleosomal dyad. (A) W-Nuc146 interacts with multiple copies of full length MeCP2 (as judged from Porod volumes;
Table 2) to form extended complexes. (B) A-Nuc147 interacts with a single copy of MeCP2 or MeCP278–305 (as shown by SEC-MALS,
Supplementary Figure S2), (C) W-Nuc165 also forms deﬁned 1:1 complexes with both versions of MeCP2. The relatively minor changes in dmax
between unbound nucleosomes and those in complex with full length MeCP2 or MeCP278–305 suggests that DNA binding domains in the C-terminal
region of MeCP2 are also engaged in interactions with this nucleosome.
Nucleic Acids Research, 2011,Vol.39, No. 10 4133nucleosomes (20). Experiments presented here, performed
at higher concentrations of both MeCP2 and nucleo-
somes, demonstrate the formation of deﬁned complexes
with nucleosomes without linker DNA (A-Nuc147).
Based on solution studies of these nucleosomes in the
absence of MeCP2 (discussed above), we propose that
MeCP2 interacts with the partially unpeeled DNA se-
quences in lieu of linker DNA. In contrast, nucleosomes
reconstituted onto 146bp of 601 sequence have highly
ordered and tightly associated DNA ends; these nucleo-
somes bind several MeCP2 molecules. Because the
complex retains an extended conformation, we propose
that these interactions are non-speciﬁc and not very
tight. In direct competition experiments MeCP2 exhibits
a clear preference for nucleosomes with linker DNA (e.g.
W-Nuc165), and prefers free DNA over these. We
conclude that tightly folded nucleosomes (such as
W-Nuc146) are a poor substrate for MeCP2, but that
DNA partially dissociated from the nucleosome represents
a substitute for interaction in the absence of linker DNA.
Several histone variants give rise to nucleosomes with
less-tightly organized DNA ends [e.g. H2A.Bbd (46);
and the centromeric variant of H3, CenpA; K.L. unpub-
lished results], suggesting the hypothesis that MeCP2
might preferentially bind to such variant nucleosomes.
MeCP2 protects 11bp of extra-nucleosomal DNA as
seen from micrococcal nuclease digestions (20), suggesting
that it binds near the nucleosomal dyad axis. Together
with our own results that MeCP2 forms a 1:1 complex
with a nucleosome that retains all four histones, and
based on SAXS data obtained with nucleosome complexes
with full length and truncated MeCP2 (Table 2), we can
build a tentative working model for the MeCP2–nucleo-
some complex (Figure 8). As observed previously (8,9) and
conﬁrmed here with independent approaches, free MeCP2
exhibits all of the hallmarks of an intrinsically disordered
and extended protein. Nucleosomes without linker DNA
(W-Nuc146) do not allow speciﬁc interactions, resulting in
several non-speciﬁcally (and presumably weakly bound)
MeCP2 molecules (Figure 8A). A-Nuc147 offers only
the partially unpeeled nucleosomal DNA for interaction
and thus only the MBD and the TRD are engaged in
binding, while the remaining 200 amino acids extend
into the solvent (Figure 8B). This is sufﬁcient to yield a
MeCP2-nucleosome complex with anomalous hydro-
dynamic properties. Upon interaction with a nucleosome
with linker DNA (W-Nuc165), the dmax values of the re-
sulting complexes suggest that MeCP2 either becomes
more compact or that it engages additional DNA
binding sites that are located in the C-terminal half of
the protein (Figure 8C). We propose the latter explanation
to be more likely, because MeCP2 clearly prefers nucleo-
somes with linker DNA over linker-less nucleosomes.
Together, our data are consistent with a model in which
MeCP2 requires at least 211bp of linker DNA for
proper engagement of all DNA binding domains. The
polyvalent binding of MeCP2 contributes to our under-
standing of how RTT mutants outside of the MBD (e.g. a
truncation at amino acid 294) may result in a diseased
state.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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